...Hendrikje M.K. van Breda; John P.F.A. Heesakkers Objectives: To give an overview of the literature concerning the clinical practice of Botulinum toxin A (BTA) treatment to meet the needs and knowledge of urologists. Methods: A literature search was performed to BTA treatment, together with a survey...

... causes can be determined should have their serum checked for BoNT/A-AB. Recurrent urinary tract infection might be a predisposing factor for BoNT/A-AB. Onabotulinumtoxin A Incontinence Children Botulinum toxin Bladder Antibodies Neurogenic detrusor overactivity 20 06 2011 10 08...

...Ricarda M. Bauer; Christian Gratzke; Alexander Roosen; Yasmin Hocaoglu; Margit E. Mayer; Alexander Buchner; Christian G. Stief; Florian May Objective: The aim of the study was a prospective assessment of patient-reported side effects in an open-label study after intradetrusor botulinum toxin...

...Takeshi Watanabe; Toshihiko Masago; Ikuo Miyagawa Aims: To examine botulinum toxin A (BTX-A)-induced apoptosis in the detrusor muscle in male rats. Methods: The bladder wall and prostate in adult male Sprague-Dawley rats were injected with BTX-A (10 U at each site). Tissues were harvested after 2...

... with considerable side effects resulting in treatment failure. In the case of failure or intolerable side effects, sacral neuromodulation (SNM) and botulinum toxin are minimally invasive and reversible alternatives. Currently, of these alternatives only SNM with InterStimTM therapy has FDA approval for use in OAB...

... hysterectomy with few adverse effects. 5 11 2004 4 05 2005 5 10 2005 Botulinum toxin Cervical cancer Detrusor areflexia Hysterectomy Urologia Internationalis Original Paper Urol Int 2005;75:247 251 DOI: 10.1159/000087803 Received: November 5, 2004 Revised and accepted: May 4, 2005...